Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.34 |
| ▸ | PREP | P48147 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28735688 | 0.80 | CHRM2 (0.41) | CHRM2CHRM1CHRM3HPGDGPR119 | |
| SCHEMBL29519744 | 0.80 | CHRM2 (0.41) | CHRM2CHRM1CHRM3HPGDGPR119 | |
| SCHEMBL24069211 | 0.78 | CHRM2 (0.44) | CHRM2CHRM1CHRM3HPGDGPR119 | |
| SCHEMBL143165 | 0.77 | CHRM2 (0.38) | CHRM2CHRM1CHRM3HPGDGPR119 | |
| SCHEMBL144061 | 0.77 | CHRM2 (0.38) | CHRM2CHRM1CHRM3HPGDGPR119 | |
| SCHEMBL30832433 | 0.74 | CHRM2 (0.41) | CHRM2CHRM1CHRM3HPGDUSP2 | |
| SCHEMBL6026752 | 0.72 | CHRM2 (0.39) | CHRM2CHRM1CHRM3HPGDUSP2 | |
| SCHEMBL1991738 | 0.72 | CHRM2 (0.42) | CHRM2CHRM1CHRM3HPGDGPR119 | |
| SCHEMBL5837112 | 0.72 | CHRM2 (0.39) | CHRM2CHRM1CHRM3HPGDGPR119 | |
| SCHEMBL4370463 | 0.72 | CHRM2 (0.39) | CHRM2CHRM1CHRM3HPGDUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100022605-A1 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022605-A1 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | NAAA, HDHD5, HACL2 | CHRM2 4824/4885CHRM1 4760/4885CHRM3 4803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.